The QualityStocks Daily Thursday, October 18th, 2018

Today's Top 3 StockMarketWatch

Small Cap Firm (PTI) +447.62%

StockMarketWatch (CCCL) +105.03%

The Street (ECYT) +57.50%

The QualityStocks Daily Stock List

Zoom Telephonics, Inc. (ZMTP)

Hotstocked, Market Exclusive, FeedBlitz, Marketbeat, Insider Tracking, Wall Street Mover, OtcWizard, 4-Traders, Real Investment Advice, Dividend Investor, SmallCapVoice, OTC Picks, and Investors Hangout reported on Zoom Telephonics, Inc. (ZMTP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Zoom Telephonics, Inc. is a foremost manufacturer of cable modems and other communications products. The Company designs, produces, markets, and supports cable modems and other communications products under the Zoom, Hayes®, and Global Village® brands. OTCQB-listed, Zoom Telephonics is based in Boston, Massachusetts.

The Company’s products include cable modems & gateways, dial-up modems, mobile broadband modems and routers, wireless networking products, ADSL gateways, Bluetooth wireless products, wireless keyboards, and ZoomGuard wireless sensors & controls. Products also include asymmetric digital subscriber line modems, wireless local area networking products, Voice Over IP products (VoIP), wired networking equipment, dialers and related telephony products, wireless sensors and controls, phone jacks and AC power adapters, and language-related specifics.

Zoom Telephonics signed an exclusive license agreement with Motorola Mobility LLC in May of 2015. The license agreement is for the Motorola brand in connection with consumer cable modem products. This includes cable modem bridges, cable modem/routers, and cable set-top boxes containing cable modems, for the United States and Canada. The agreement began on January 1, 2016 and runs through December 31, 2020.

Zoom Telephonics announced in September 2017 the signing of an amendment to its license agreement with Motorola Mobility to include the exclusive international rights for the Motorola brand for consumer-grade cellular modems and gateways, DSL modems and gateways, and MoCA (Multimedia over Coax) adapters. The amendment also grants Zoom Telephonics non-exclusive global rights to use the Motorola brand for consumer-grade cellular home sensors. These are products designed, marketed, and sold for use by consumers for their personal, family, or household use.

This past August, Zoom Telephonics reported financial results for its 2018 Q2 ended June 30, 2018. 2018 Q2 financial highlights versus the prior year’s period include Net Sales increasing10.2 percent to $7.5 million because of the strength of Zoom’s Motorola brand products. Gross Margin improved to 36.3 percent from 32.1 percent. Net Income was roughly $47,000 or $0.00 per share, versus a Net Loss of $269,000 or $0.02 per share.

This week, Zoom Telephonics announced that it appointed Mr. Joseph Lee Wytanis as President and Chief Operating Officer (COO). Mr. Wytanis’ start date with Zoom Telephonics is October 29, 2018. Mr. Frank Manning will remain as the Company's Chief Executive Officer (CEO) and Chairman.

Mr. Wytanis is a high technology senior level executive. He has wide-ranging experience working with consumer electronic and communication companies offering products and/or services globally.

Zoom Telephonics, Inc. (ZMTP), closed Thursday's trading session at $1.91, even for the day, on 2,060 volume with 3 trades. The average volume for the last 3 months is 7,886 and the stock's 52-week low/high is $1.00/$4.11.


GB Sciences, Inc. (GBLX)

Stockgoodies, SmallCapVoice, Cannabis Financial Network News, Money Morning, SeriousTraders, Otcstockexchange, PennyStockInformer, StocksToBuyNow, PennyStockLaboratory,, Pumps and Dumps, Whisper from Wall Street, Wall St Report, CFN Media Group, AllPenny Stocks, Wall Street Resources and TradeThesePicks reported earlier on GB Sciences, Inc. (GBLX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

GB Sciences, Inc. is a biopharmaceutical Research and Development (R&D) company. Its focus is on creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. GB Sciences’ R&D team is pursuing new formulations derived from specific strains of cannabis, creating patented formulations that will help patients. GB Sciences is based in Las Vegas, Nevada.

The chief directive of GB Sciences since its inception has been the creation of a quality-controlled cannabis cultivation and extraction facility to provide the compounds for formulating medicines to treat a wide assortment of diseases. The Company has added its own medical-grade retail brand to its portfolio. This portfolio includes granted-medical and provisional-recreational use Nevada cultivation licenses and patent-pending medical formulations.

GB Sciences provides clean, reliable raw materials for manifold cannabis products and research initiatives. The Company is creating novel formulations and seeking patents for treatments that will directly assist patients.

GB Sciences has its Cultivation Lab facility in Las Vegas. When fully operational, Cultivation Lab will contain 7,200 cannabis plants under 600 grow lights within its 28,000 ft. The expectation is that Cultivation Lab will generate about $10 million in yearly revenue.

GB Sciences and Cura Cannabis Solutions have executed a production agreement to produce high quality cannabis oils and related products using the GB Sciences production license operated by the GB Sciences' Cultivation Labs™. Cura Cannabis Solutions is the foremost provider of premium cannabis oil and hemp oil to the legal domestic and worldwide markets. The production agreement guarantees GB Sciences a set royalty on every gram produced and sold under the agreement.

GB Sciences announced this past February that it was issued its production license and commenced full production operations in the Las Vegas facility. Production license partners include Relax With Happy™ (RWH), a new venture co-founded by veteran cannabis chef, Deliciously Dee™, and Cura Cannabis Solutions, maker of the best-selling cannabis brand on the West Coast, Select Oil.

GB Sciences has filed a new provisional patent application on the use of cannabis-based therapies for the manipulation of cannabis-sensitive ion channels in sensory neurons, which contribute to chronic inflammatory pain conditions, peripheral neuropathy, urinary cystitis, asthma, and specific types of hearing loss.

The Company’s drug development team believes that these new cannabis-based treatments could signal the beginning of ‘individualized medicines’ from the cannabis plant through re-establishing balance in each individual patient’s endocannabinoid system.

This week, GB Sciences was named as one of the ten select cannabis companies in North America according to a study conducted by a leading investment banking firm in its June 20, 2018 Industry Report on Medical Cannabis. The report included extensive research and analyst coverage on 31 public and 31 private cannabis companies from the United States and Canada. GB Sciences was the only U.S. publicly traded company to make the list of ten companies.

GB Sciences, Inc. (GBLX), closed Thursday's trading session at $0.34, down 1.02%, on 624,479 volume with 369 trades. The average volume for the last 3 months is 1,547,090 and the stock's 52-week low/high is $0.21/$1.56.


Lixte Biotechnology Holdings, Inc. (LIXT)

Penny Stock Hub, Spotlight Growth, Real Pennies, Proactive Investors, YCharts, Stockhouse, 4-Traders, MarketWatch, InvestorsHub, and Simply Wall St reported on Lixte Biotechnology Holdings, Inc. (LIXT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Lixte Biotechnology Holdings, Inc. is a drug discovery company headquartered in East Setauket, New York. It employs biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The Company’s product pipeline encompasses two major categories of compounds at different stages of pre-clinical and clinical development, which it believes have broad therapeutic potential for cancer and other debilitating and life-threatening diseases. A clinical-stage company, Lixte Biotechnology lists on the OTC Markets’ OTCQB.

The Company’s commitment is to discovering drugs for more effective treatments for cancer. It has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. Lixte’s cancer drug development strategy has led to the discovery of novel compounds.

The deacetylase inhibitors are in pre-clinical development for the prevention and treatment of neurodegenerative diseases, traumatic brain injury, and topically for fungal dermatitis. The phosphatase inhibitors are in pre-clinical development for decreasing the extent of tissue damage following stroke, heart attack, and septic shock.

Lixte Biotechnology’s current drug portfolio includes inhibitors of serine/threonine protein phosphatases that are crucial to cell division. In addition, the Company’s portfolio includes DNA damage repair and inhibitors of protein deacetylases, which regulate pathways of gene expression and protein degradation.

The Company’s unique phosphatase inhibitor is LB-100, its lead compound. LB-100 is in a Phase I clinical trial at two NCI designated Comprehensive Cancer Centers and three U.S. Oncology Research locations. Lixte granted an exclusive license of its LB-100 for the treatment of hepatocellular carcinoma (HCC) in Asia to Taipei Medical University (TMU). LB-100 is not currently approved for treatment of HCC.

In August, Lixte Biotechnology Holdings announced that it entered into a Clinical Trial Agreement and Exclusive License Agreement with Moffitt Cancer Center to conduct a Phase 1b/2 study of the safety and therapeutic benefit of the Company’s lead clinical compound, LB-100, in patients with myelodysplastic syndrome (MDS). This trial will enter low and intermediate-1 risk MDS patients, including those with del(5q) MDS who have failed or are intolerant of standard treatment.

Last week, Lixte announced that it submitted an IND to the Food and Drug Administration (FDA) to conduct a Phase 1b/2 trial of the safety and therapeutic benefit of lead clinical compound, LB-100, in patients with low and intermediate-1 risk myelodysplastic syndrome (MDS) who have failed or are intolerant of standard treatment. The study will take place at Moffitt Cancer Center, Tampa, Florida.

Lixte Biotechnology Holdings, Inc. (LIXT), closed Thursday's trading session at $1.1235, up 24.83%, on 36,482 volume with 35 trades. The average volume for the last 3 months is 19,850 and the stock's 52-week low/high is $0.12/$1.84.


Noble Roman’s, Inc. (NROM)

Penny Stock Hub, InvestorVillage, TipRanks, Simply Wall St, TaglichBrothers, Insider Financial, Marketbeat, FeedBlitz, Equity Clock, Penny Stock Tweets, The Bowser Report, Wallet Investor, StockOodles, Wall Street Resources, YCharts, MicroCapClub, SmallCapVoice, and Stockopedia reported on Noble Roman’s, Inc. (NROM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Noble Roman's, Inc. sells and services franchises and licenses for non-traditional foodservice operations and stand-alone take-n-bake locations. The Company’s business model comprises three growth venues. These are Grocery Take-n-Bake Licensing; Non-Traditional Franchising; and Stand-Alone Franchising. Noble Roman’s is headquartered in Indianapolis, Indiana. The Company lists on the OTC Markets Group’s OTCQB.

Noble Roman’s franchises and licenses under the Noble Roman’s Pizza, Noble Roman’s Take-N-Bake, Tuscano’s Italian Style Subs, and Noble Roman's Craft Pizza & Pub (CPP) trade names. The Company has awarded franchise and/or license agreements in all 50 U.S. States plus Washington, D.C. Additionally, it has awarded franchise and/or license agreements in Canada, Puerto Rico, the Bahamas, Italy, and the Dominican Republic.

The first Noble Roman's Craft Pizza & Pub (CPP) opened on January 31, 2017 in Westfield, Indiana in the Monon Marketplace on Main Street/Highway 32 across from Grand Park. Noble Roman's announced in May 2018 that it opened a fourth location of its new-generation, stand-alone pizzeria concept, Noble Roman's Craft Pizza & Pub (CPP). The newest location is in Carmel, Indiana on Main Street just east of Meridian Street/US 31N.

Concerning Non-Traditional Venues, these are typically located in a host facility whose primary business is other than foodservice. These facilities can add pizza-focused foodservice as a Revenue Center; as a Facility Draw; and as an Employee Benefit.

Regarding Stand-Alone Venues, these are traditional pizzeria locations and Take-n-Bake locations. There is a merging over time between the kinds of Stand-Alone Venues: Live Yeast Dough; Hand-Rolled Breadsticks; and Baking Services.

Grocery Take-n-Bake Licensing involves licensing to sell Noble Roman’s Pizza. This is a component program using Noble Roman’s ingredients, in which delis assemble pizzas from standard Noble Roman’s ingredients.

Noble Roman's intention is to hasten the development of Craft Pizza & Pub (CPP) locations via franchising. General franchising is planned for Indiana and surrounding areas with an emphasis on franchisees that can become multi-unit operators. In addition, Noble Roman’s will also pursue development of other markets deemed suitable for the concept with experienced multi-unit operators.

Noble Roman’s stated in August 2018 that all four company-owned and operated Craft Pizza & Pub (CPP) locations continue to out-perform pre-opening expectations. During the three-month and six-month periods ended June 30, 2018, total Revenue from those locations were $1.2 million and $2.4 million, respectively.

Noble Roman’s, Inc. (NROM), closed Thursday's trading session at $0.60, down 1.64%, on 36,600 volume with 13 trades. The average volume for the last 3 months is 29,346 and the stock's 52-week low/high is $0.50/$0.87.


Elite Pharmaceuticals, Inc. (ELTP)

Promotion Stock Secrets, Pennybuster, SmallCapVoice, Top Stock Picks, PennyStocks24, TopPennyStockMovers, Marketbeat, and Stock Analyzer reported on Elite Pharmaceuticals, Inc. (ELTP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. A specialty pharmaceutical company, it is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products and niche generic products. The Company specializes in oral sustained and controlled release drug products that have high barriers to entry. Elite Pharmaceuticals is based in Northvale, New Jersey, where it operates a GMP and DEA registered facility for research, development, and manufacturing.

The Company also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.). Elite owns generic and Over-the Counter (OTC) products that have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy’s Laboratories, and Glenmark Pharmaceuticals, Inc., USA. 

Elite’s lead pipeline products include abuse-deterrent opioids that use the Company’s patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain.

Regarding Elite Pharmaceuticals’ proprietary abuse-deterrent technology, ART™, it is a multi-particulate capsule that contains an opioid agonist in addition to naltrexone, an opioid antagonist used chiefly in the management of alcohol dependence and opioid dependence. When the product is taken as intended, the design of naltrexone is to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed.

At present, Elie Pharmaceuticals has eight commercial products selling, five products under review pending approval by the Food and Drug Administration (FDA), additional approved products pending manufacturing site transfer, and the NDA filing for SequestOx™.

Recently, Elite Pharmaceuticals announced it filed an Abbreviated New Drug Application (ANDA) with the FDA for a generic version of an extended-release CNS stimulant. The ANDA represents the filing of a second product co-developed with SunGen Pharma, LLC. This past February, Elite Pharmaceuticals and SunGen Pharma filed an ANDA to a generic version of an immediate-release CNS stimulant.

This week, Elite Pharmaceuticals announced that it received approval of the Company’s abbreviated new drug application (ANDA) from the FDA for generic Percocet® (Oxycodone Hydrochloride and Acetaminophen, USP CII) 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg tablets.

The indication for this product is for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are insufficient.

Elite Pharmaceuticals, Inc. (ELTP), closed Thursday's trading session at $0.0791, up 0.64%, on 270,730 volume with 27 trades. The average volume for the last 3 months is 766,787 and the stock's 52-week low/high is $0.056/$0.145.


GulfSlope Energy, Inc. (GSPE)

OTC Markets, InvestorsHub, MarketWatch, Stockhouse, Morningstar, Equity Clock, and Financial Times reported on GulfSlope Energy, Inc. (GSPE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

GulfSlope Energy, Inc. is an independent oil and natural gas company concentrating on exploring offshore U.S. Gulf of Mexico. The Company uses 2.2 million acres of 3D seismic data to identify high quality exploration prospects. Its team has a track record of discovering and developing multi-billion-dollar projects globally, with greater than 300 years of combined experience in the oil and gas exploration industry. OTCQB-listed, GulfSlope Energy is based in Houston, Texas.

GulfSlope Energy’s portfolio has diversity in size, water depth, drilling depth, and risk profile. The Company’s target is the Shelf Miocene (2.2 MM Acres - 440 Blocks).

GulfSlope’s current emphasis is on pre-drill operations. It has a hybrid operating model with a preference to operate. The Miocene Subsalt Play – La Shelf has large resource potential; is low to moderate risk; has moderate drilling and development costs; has shortened times to initial production, and enhanced economics.

Regarding its Phase 1 Drilling Program, GulfSlope has high-graded five prospects with mean unrisked resource potential of 623 MMboe. The Company is looking to capitalize on strategic advantages provided by exploration work to identify undervalued producing assets.

GulfSlope Energy has more than 2 billion boe of net conventional recoverable resources. It has 23 lease blocks with 19 drilling prospects ranging from 30-280 MMboe. The average size of the prospects is 120 MMboe.

GulfSlope Energy and Texas South Energy, Inc. (TXSO) have entered into a strategic partnership with Delek Group Ltd., a global independent oil and gas company based in Israel. The Companies and Delek have mutually agreed to pursue oil and natural gas opportunities in the Gulf of Mexico.

Yesterday, GulfSlope Energy announced that it has the Rowan Ralph Coffman jack-up rig under tow in the Gulf of Mexico to the Vermilion Area, South Addition Block 378.  GulfSlope plans to begin drilling operations at the Canoe Prospect by August 1, 2018, pending final rig inspection and drilling approval from the Bureau of Ocean Management (BOEM).

Immediately after the drilling of the Canoe well, GulfSlope Energy will mobilize the Ralph Coffman to drill the initial exploration well on the Tau prospect on Ship Shoal Area, South Addition Blocks 336/351. 

GulfSlope Energy, Inc. (GSPE), closed Thursday's trading session at $0.0485, up 1.04%, on 360,855 volume with 36 trades. The average volume for the last 3 months is 1,313,456 and the stock's 52-week low/high is $0.0346/$0.20.


Nexeon MedSystems, Inc. (NXNN)

NetworkNewsWire, Penny Stock Hub, Awesome Penny Stocks, TipRanks, Stockhouse, Stockopedia, Zacks, Taglich Brothers, YCharts, Wallet Investor, Street Insider, Barchart, InvestorsHub, and Stockwatch reported on Nexeon MedSystems, Inc. (NXNN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Nexeon MedSystems, Inc. focuses on providing inventive neurostimulation products. OTCQB-listed, the Company’s emphasis is on providing neurostimulation products that improve the quality-of-life of patients suffering from debilitating neurological diseases. Nexeon MedSystems has offices in Dallas, Texas and Liege, Belgium (Nexeon MedSystems Belgium SPRL).

A global bioelectronics medical device company, Nexeon has developed and commercialized a neurostimulation system. This system can be used to treat an array of neurological diseases. Neurostimulation systems are used to restore neuronal function. The Company’s SYNAPSE™ device is the platform utilized in a process called Deep Brain Stimulation (DBS).

The platform acts like a brain pacemaker sending electrical pulses to specifically targeted areas in the brain. SYNAPSE™ lessens shortcomings in present-day DBS therapy. It enables the detection, measurement, and collection of brain signals, while at the same time providing targeted DBS therapy. In addition, it provides directional stimulation that limits side effects.

Furthermore, multiple stimulation frequencies allow increased therapy range. Also, rechargeable means a greater range of available therapies and rechargeable enables one surgery versus many.

Nexeon Medsystems Belgium, SPRL (NMB) recently acquired Medi-Line. This is a Belgian medical device manufacturer. At present, Medi-Line serves 34 medical device customers in 16 nations. It has multi-year contracts with Fortune 500 companies.

Nexeon MedSystems closed in 2017 the acquisition of Nexeon MedSystems Belgium, SPRL (previously Rosellini Scientific Benelux) and its wholly-owned subsidiaries Med-Line S.A. and its holding company INGEST, SPRL. Moreover, the Company completed regulatory pathway review with the European regulatory body DEKRA and the Food and Drug Administration (FDA) for its flagship deep brain stimulation product.

Last month, Nexeon MedSystems announced it received an $830,000 grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). This grant award, received via its wholly-owned subsidiary Nexeon MedSystems Puerto Rico Operations Company Corporation (NMPROC), will support the development of novel cloud-based software to improve programming for deep brain stimulation. The NINDS intention is to fund $1.5 million over 3 years, subject to yearly review and approval, with the remaining funds directed towards clinical evaluation of the software’s performance.

Last week, Nexeon MedSystems announced it submitted an application in response to the FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder. Opioid Use Disorder (OUD), characterized by problematic symptoms of addiction to and withdrawal from opioids, is part of a public health crisis affecting over 2 million Americans with considerable physical, emotional, and cognitive impairment. Nexeon MedSystems is developing the Zero Point™ Stimulation System, a non-invasive neurostimulation device designed to provide low-levels of electrical stimulation to activate nerves for the treatment of several diseases and disorders, including opioid withdrawal.

Nexeon MedSystems, Inc. (NXNN), closed Thursday's trading session at $6.50, even for the day, on 100 volume with 1 trade. The average volume for the last 3 months is 114 and the stock's 52-week low/high is $3.00/$9.50.


PetroShare Corp. (PRHR)

DreamTeamNetwork, SmallCapVoice, Stockhouse, InvestorsHub, and CapitalCube reported earlier on PetroShare Corp. (PRHR), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

PetroShare Corp. is a domestic oil and natural gas exploration and development company. It targets capital deployment opportunities in established unconventional resource plays. The Company formed to investigate, acquire, and develop oil and gas properties in the Rocky Mountain and mid-continent regions of the United States. PetroShare is headquartered in Englewood, Colorado and the Company lists on the OTC Markets Group’s OTCQB.

PetroShare’s properties include Todd Creek Farms (Southern Wattenberg Field, NE Colorado; Niobrara and Codell Oil and Gas Development). The Company’s present focus is in the Niobrara/Codell formations and adjacent oil and gas producing zones in the Rocky Mountain region. Specific targets are in the Wattenberg field within the DJ Basin of northeast Colorado.

PetroShare is expanding its group of properties through organic drilling and development, in addition to strategic acquisitions and joint ventures (JVs). It acquired an initial acreage position of roughly 1,280 gross acres (333 net acres) in the core of the oil dominated Niobrara/Codell resource development fairway in the southern end of the Greater Wattenberg Field area of NE Colorado.

The Company’s properties additionally include the Buck Peak Prospect (Sand Wash Basin, NW Colorado; Niobrara Oil Development). This Prospect is 7,700 gross acres (1,000 net acres) located in Moffat County. PetroShare has drilled and completed two producing wells in this prospect.

The Buck Peak Prospect targets oil and associated wet gas from the fractured Niobrara Shale formation. The Company’s Shook pad development program comprises 6 Codell wells and 8 Niobrara wells targeting all three Niobrara benches.

PetroShare has secured the rights-of-way required to start pipeline construction and hook up on its Shook pad. It has also assembled six additional drill site spacing units (DSUs) with surface use agreements across its South Brighton assets and has approximately 100 permits approved, submitted or in process for operated horizontal wells in the region.

Recently, PetroShare provided an update on its operated and non-operated activities in the Wattenberg Field in the Denver Julesberg Basin in Colorado.

Mr. Frederick J. Witsell, PetroShare President, said, "Our participation in non-operated wells this year is contributing to production growth and we estimate that we will average between 900-1,200 BOED during the second quarter, which is up from the 680 BOED rate in the first quarter of 2018. We are currently completing the last of 14 wells on our operated Shook pad.”

PetroShare Corp. (PRHR), closed Thursday's trading session at $1.37, up 1.48%, on 5,500 volume with 3 trades. The average volume for the last 3 months is 2,770 and the stock's 52-week low/high is $0.75/$1.54.


Liberty Leaf Holdings Ltd. (LIBFF)

NetworkNewsWire, Penny Stock Hub, Stocks To Buy Now, TipRanks, Stockwatch, Investorx, Barchart, Capital Cube, Stockhouse, The Seed Investor, Cannabis News Wire, MarketWatch, InvestorsHub, and Investors Hangout reported on Liberty Leaf Holdings Ltd. (LIBFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Liberty Leaf Holdings Ltd.’s focus is to build and support a diverse portfolio of cannabis-sector businesses. This includes cultivation, cannabidiol (CBD)/tetrahydrocannabinol (THC) products, biotechnology research and supply-chain products within this fast-developing sector. Liberty Leaf Holdings is based in Vancouver, British Columbia.

The Company works to acquire partnership interests in up-and-coming and established companies in the medicinal and recreational cannabis arena. Liberty Leaf operates in Canada and is looking to enter the varied legal cannabis markets in North America.

Liberty Leaf Holdings announced in December of 2017 that it acquired a majority interest in Just Kush Enterprises. Just Kush owns complete control over a current Medical Marijuana Access Regulations (MMAR)-licensed production facility. This acquisition complements Liberty Leaf Holdings’ purchase in 2016 of North Road Ventures. North Road concentrates on the value-added aspect of the cannabis product processing business, sales, and complementary distribution. North Road Ventures is a developing distributor of cultivated and manufactured cannabis products to licensed legal retailers. North Road is expanding into the recreational market.

Mr. Will Rascan, Liberty Leaf Holdings’ President and Chief Executive Officer, announced in March 2018 the signing of an agreement between North Road Ventures, a wholly-owned subsidiary of Liberty Leaf, and Cannabis Compliance, Inc. (CCI). Under the agreement, CCI will be responsible for guiding the Good Manufacturing Practice (GMP)-compliant processing/production of North Road's cannabis-containing and other finished products.

Last month, PUF Ventures, Inc., an advanced Access to Cannabis for Medical Purposes Regulations (ACMPR) license applicant, and Liberty Leaf Holdings announced the execution of a Memorandum of Understanding (MOU) that outlines the basis where the Parties will undertake the creation of a joint venture (JV) partnership to develop a medical cannabis project for the cultivation and sale of medical cannabis in Greece. At present, the JV company is in talks with potential local partners with suitable resources and expertise to participate in the development of a large-scale, medical cannabis commercial cultivation operation.

This week, Liberty Leaf Holdings announced that work at Just Kush is now complete on the buildout of its "Phase I" cultivation production facility. Therefore, on October 29-30, 2018, Cannabis Compliance (CCI) will conduct its site visit walk through of the Just Kush facility and gather video footage as part of the Affirmation of Readiness (AOR) submission to Health Canada.

Mr. Will Rascan said, "I am very excited with the final result of the completed buildout. Coupled with our innovative technologies, what this means is that Just Kush can now officially notify Health Canada that it's ready for cannabis licensing."

Liberty Leaf Holdings Ltd. (LIBFF), closed Thursday's trading session at $0.1528, down 2.24%, on 33,091 volume with 22 trades. The average volume for the last 3 months is 29,967 and the stock's 52-week low/high is $0.084/$0.807.


Kona Gold Solutions, Inc. (KGKG)

Stockopedia, Information Vine, Penny Stock Tweets, The Street, Business Insider, SmallCapVoice, PinkInvesting, Simply Wall St, SmallCapExclusive, EmergingGrowth, Insider Financial, YCharts, Stockwatch, Dividend Investor, InvestorsHub, MarketWatch, OTC Markets, Barchart, 4-Traders, Investors Hangout, and MicroCapDaily reported on Kona Gold Solutions, Inc. (KGKG), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Kona Gold Solutions, Inc. is a hemp lifestyle brand focused on product development in the functional beverage sector. The Company has developed a premium Hemp Infused Energy Drink line, Energy shots, and Apparel. Kona Gold is a member of the Hemp Industries Association (HIA). The Company has its corporate office in Melbourne, Florida.

Kona Gold’s wholly-owned subsidiaries are Kona Gold, LLC; HighDrate, LLC; and BitHive Mining, LLC. Kona Gold is in the process of selling its subsidiary BitHive Mining to a private company as it leaves the cryptocurrency market to focus on its core beverage business.

The Company’s HighDrate subsidiary has developed the beverage industry’s first CBD Energy Water. It is available in four flavors – Watermelon, Kiwi Strawberry, Tropical Coconut, and Georgia Peach. This subsidiary’s emphasis is on consumers that lead an active lifestyle and require a balanced beverage that will meet their needs of providing their mind and body with a focused boost and fast recovery.

In early October, Kona Gold Solutions announced it entered into a distribution agreement with Liquid Culture Enterprises.  Liquid Culture will be distributing the Company’s Kona Gold Hemp Energy Drinks and HighDrate CBD Energy Waters in the seven counties of South Carolina they cover. Liquid Culture Enterprises is a distributor of beverages and snacks.

Last week, Kona Gold Solutions announced it is extending its popular Hemp Energy Drink product line to include new flavors. Two new flavors the Company is developing and planning to bring to market in late November are Cherry Vanilla and Cotton Candy.  Kona Gold has amassed feedback and statistics from industry experts and a number of large distribution houses to ascertain what flavors would be the most successful.

The announcement comes subsequent to Kona Gold signing two new distributors in North and South Carolina. Furthermore, the Company is producing its new larger 12 oz slim line cans. These will be replacing its 8.4 oz offering.  The new 12 oz Hemp Energy drinks will be available in late October. They will include Kona Gold’s popular Classic, Sugar Free, and all new Platinum flavors.

Kona Gold Solutions, Inc. (KGKG), closed Thursday's trading session at $0.0561, down 6.50%, on 25,690,696 volume with 984 trades. The average volume for the last 3 months is 7,210,669 and the stock's 52-week low/high is $0.005/$0.0678.


Solbright Group, Inc. (SBRT)

Street Insider, Penny Stock Hub, OTC Dynamics, InvestorsHub, Wallmine, Business Insider, OTC Markets, YCharts, Marketbeat, Stockhouse, Barchart, MarketWatch, 4-Traders, TradingView, NetworkNewsWire, Morningstar, CapitalCube, Simply Wall St, GuruFocus, WalletInvestor, WhaleWisdom, and Amigo Bulls reported on Solbright Group, Inc. (SBRT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Solbright Group, Inc. is an industrial automation and energy management company. It provides Industrial Internet of Things (IIoT) solutions, which help commercial and industrial facilities increase efficiency and lessen cost. The Company’s concentration is towards the development and commercialization of an Internet of Things (IoT) software platform, which supports Big Data applications that complement its energy management services.

Established in 1999, Solbright Group has its corporate office in Newark, New Jersey. The Company previously went by the name Arkados Group, Inc. It changed its name to Solbright Group, Inc. in November of 2017.

The Company has pioneered smart energy solutions and IoT technologies since 2013. Solbright Group’s corporate vision is to help facility operators throughout the U.S. improve the operational performance of their facilities via its technology, renewable energy, as well as energy conservation solutions.

The Company delivers technology solutions for building and machine automation and energy conservation that complement its energy conservation services such as LED lighting retrofits, HVAC system retrofits and solar engineering, procurement and construction services.

Regarding its platform, BrightAI is a converged IoT platform. It monitors any IAQ sensor, mechanical sensor, meter, or BACnet device in a facility. BrightAI features energy management and predictive maintenance applications through a cloud control dashboard.

In January of this year, Solbright Group announced a new agreement with Ying Wu College of Computing at New Jersey Institute of Technology (NJIT) to advance research and development (R&D) of its industrial internet of things (IIoT) software platform with an emphasis on taking advantage of blockchain technology for enhanced security and energy savings monetization.

The design of the partnership is to take advantage of the prestigious advanced research capability of the Ying Wu College of Computing (YWCC) at NJIT to jointly research functional security applications for Solbright Group's advanced IoT platform built for commercial and industrial real estate markets utilizing blockchain technology.

Last week, Solbright Group and M2M Spectrum Networks, LLC (d/b/a Iota), a company that provides complete IoT communication solutions, announced an agreement in which the two companies will work together to provide a comprehensive, next-generation Smart Facilities line of products and services called SF Net. Iota provides wide-ranging solutions for creating, connecting and managing communications for IoT.

SF Net combines a network and set of solutions, which will provide corporate and campus facility managers with a one-stop, turnkey-installed, facility-wide, carrier-grade network and applications platform with a broad set of ready-to-implement applications.

Solbright Group, Inc. (SBRT), closed Thursday's trading session at $0.79, up 1.28%, on 30,840 volume with 11 trades. The average volume for the last 3 months is 183,747 and the stock's 52-week low/high is $0.275/$1.55.


MMEX Resources Corp. (MMEX)

Stockhouse, InvestorsHub, HydroCarbonProcessing, MarketWatch, and OTC Markets reported on MMEX Resources Corp. (MMEX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MMEX Resources Corp. concentrates on the acquisition, development and financing of oil, gas, refining and infrastructure projects in Texas, Peru, and other countries in Latin America. MMEX formed to engage in the exploration, extraction, refining and distribution of oil, gas, petroleum products and electric power. A development-stage company, MMEX Resources is headquartered in Fort Stockton, Texas.

MMEX Resources’ chief areas of interest include the acquisition and potential development of refining, oil & gas assets in Texas, and the acquisition of oil and gas properties in Peru. In addition, main areas of interest include crude, oil and product export opportunities in Latin America, and the development of terminals, storage, refining, oil & gas in Brazil.

The Company’s projects include the Pecos County Refinery Project, Fort Stockton, Texas. Phase 1 of the project is a 10,000 BPD Crude Distillation Unit. Phase 2 is a 100,000 BPD Large-Scale Refinery.

This project is in Sulfur Junction, which is about 20 miles northeast of Fort Stockton. The project is strategically located close to oil production in West Texas, with storage capability.

MMEX Resources announced this past February that it retained Interstate Treating, Inc. (Odessa, Texas) to be the main contractor for the engineering, procurement and construction of MMEX’s planned 10,000 barrel-per-day (bpd) crude oil distillation unit in Pecos County. Interstate Treating is a leading provider of complete turnkey construction services to the gas treating and processing industry.

MMEX Resources has signed an off-take agreement with Pilot Thomas Logistics. The off-take agreement is for the sale of its diesel fuel production from Phase 1 of the MMEX refinery project in Pecos County, a 10,000 BPD Crude Distillation Unit. The agreement provides for Pilot Thomas Logistics to obtain 100 percent of the diesel production from Phase 1, roughly 4,200 barrels per day, for markets in the Permian Basin area primarily for use in drilling operations.

MMEX Resources broke ground on Phase 1 of the MMEX Refinery Project in Pecos County in mid-November 2017. The Company started and completed road construction on its easement acquired from the University of Texas Lands, entered into the above-mentioned diesel product sales agreement with Pilot Thomas Logistics and entered into a trucking transportation agreement with Penta Operating LLC.

MMEX Resources Corp. (MMEX), closed Thursday's trading session at $0.0013, even for the day, on 12,594,225 volume with 37 trades. The average volume for the last 3 months is 26,410,348 and the stock's 52-week low/high is $0.001/$0.0182.

chart, Inc. (CRMZ)

Zacks, InvestorsHub, Barchart, MarketWatch, Morningstar, CapitalCube, Last10k, Glassdoor, 4-Traders, Business Wire, Marketbeat, Stockhouse, YCharts, and Marketwired reported on, Inc. (CRMZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter., Inc. provides interactive business-to-business (B2B) Internet-based services for corporate credit and procurement professionals globally. In essence, the Company is a financial risk analysis and news service for credit, supply chain, as well as financial professionals. In addition, it offers solutions that can help ease private company financial risk assessment.

CreditRiskMonitor is headquartered in Valley Cottage, New York. The Company lists on the OTC Markets Group’s OTCQX.

CreditRiskMonitor’s main expertise and emphasis is on financial analysis of public debt and equity companies. Its service offers comprehensive commercial credit reports and financial risk analysis covering public companies around the world.

The heart of CreditRiskMonitor’s fundamental service is its 96 percent accurate FRISK® score, formulated to evaluate bankruptcy risk in public companies within a 12-month window. The FRISK® score incorporates several critical risk indicators. This includes crowdsourced click patterns of credit professionals and other subscribers.

The Company also has other features of its fundamental service. These include Moody’s and Fitch bond agency ratings; timely email alerts on news, risk and ratings changes; key financial ratios and trends; the Altman Z”-Score; the PAYCE™ score, and the FRISK® Stress Index, among other features.

CreditRiskMonitor also provides Institutional Risk Analytics counterparty quality scores and financial data from the Federal Financial Institutions Examination Council call reports covering banks. It also provides company background information, and trade payment reports, and also public filings on millions of companies in the U.S.

Last month, CreditRiskMonitor reported that for the three months ended March 31, 2018, Revenues increased 4 percent to $3.37 million versus $3.24 million in the prior year’s Q1. The Net Loss for the quarter was roughly $255,400 versus a Net Loss of approximately $244,300 in the year ago period.

Cash and cash equivalents decreased roughly $15,300 since 2017 year-end, to $8.72 million. It was down $123,700 from the balance at March 31, 2017., Inc. (CRMZ), closed Thursday's trading session at $2.15, up 7.50%, on 2,000 volume with 3 trades. The average volume for the last 3 months is 450 and the stock's 52-week low/high is $1.40/$2.74.


AIT Therapeutics, Inc. (AITB)

NetworkNewsWire, Zacks, Wolfstreet, MarketWatch, Emerging Growth, Morningstar, Stockhouse, Stockopedia, TradingView, Barchart, Insider Financial, Canadian Insider, Street Insider, last10k, Wallet Investor, GuruFocus, Real Investment Advice, 4-Traders, TipRanks, and InvestorPlace reported on AIT Therapeutics, Inc. (AITB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AIT Therapeutics, Inc. is a clinical-stage medical device and biopharmaceutical company based in Garden City, New York. The Company focuses on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions. These include serious lung infections and pulmonary hypertension. AIT Therapeutics also has an office in Ness Ziona, Israel. The Company lists on the OTC Markets Group’s OTCQB.

AIT’s technology originated at the University of British Columbia, Department of Infectious Disease in Vancouver. In 2011, Advanced Inhalation Therapies (AIT) was established and the Company developed a proprietary technology to safely deliver Nitric Oxide (NO) gas to patients with bronchiolitis and cystic fibrosis. In 2017, AIT Therapeutics became a publicly traded company.

At present, AIT Therapeutics is applying its therapeutic expertise to treat lower respiratory tract infections not effectively addressed with present standards of care, and also pulmonary hypertension, in different settings. The Company is now advancing its pioneering NO Generator and Delivery System in clinical trials for the treatment of bronchiolitis and severe lung infections including nontuberculous mycobacteria (NTM).

AIT Therapeutics’ propriety generator and delivery system generates NO from room air. This eliminates the need for costly and cumbersome cylinders. The Company’s system allows for numerous significant advantages over approved NO cylinder based systems now used in hospitals worldwide and may allow for use in the home setting.

AIT has conducted greater than 2,100 treatments in more than 85 patients across 7 studies at “high” NO concentrations. There are no serious adverse events related to NO therapy. NO is recognized as an important molecule involved in numerous physiological and pathological processes. NO is naturally produced by the body’s immune system to provide a first line of defense against invading pathogens. NO is a powerful molecule and has a short half-life of a few seconds in the blood. This enables it to be cleared quickly from the body.

In late July of this year, AIT Therapeutics announced that it started commercial development for its ventilator compatible NO generator and delivery system with Sparton Corporation. AIT and Sparton expect to complete the process in about 6 months. AIT will make a 510(k) submission to the Food and Drug Administration (FDA) soon thereafter. Sparton is a leader in the design and manufacture of highly complex electromechanical devices.

This week, AIT Therapeutics announced a poster presentation on inhaled NO at the North American Cystic Fibrosis Conference, taking place October 18-20, 2018 in Denver, Colorado. This poster will contain results of high-dose nitric oxide as an antibacterial agent in the treatment of Mycobacterium abscessus complex (MABSC). MABSC is one of the most antibiotic-resistant pathogens and difficult to treat species of nontuberculous mycobacteria (NTM). Presently, there are no approved treatments for MABSC.

AIT Therapeutics, Inc. (AITB), closed Thursday's trading session at $5.35, up 1.90%, on 12,719 volume with 32 trades. The average volume for the last 3 months is 6,728 and the stock's 52-week low/high is $2.05/$10.00.


The QualityStocks Company Corner

Marifil Mines Ltd. (TSX.V: MFM) (OTC: MFMLF)

The QualityStocks Daily Newsletter would like to spotlight Marifil Mines Ltd. (MFMLF).

Vancouver-based junior exploration company Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) this morning announced its reception of complete assay results for its 2018 diamond core drilling program at its San Roque property. To view the full press release, visit:

Marifil Mines Ltd. (TSX.V: MFM) (OTC: MFMLF), headquartered in Vancouver, Canada, is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. A rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle,” which include 15,267 hectares spanning its recently acquired Ratones and Fraile claims, as well as two lithium properties covering the southern portions of the Carachi Pampa salar in the Argentine province of Catamarca.

The company’s property also includes the Las Aguilas nickel-copper-cobalt deposit property, with more than four contiguous claims in the San Luis province of Argentina. The Las Aguilas property, which is 100% owned by Marifil, is noted as one of the largest cobalt properties in Argentina. Other noteworthy properties in the company’s portfolio include the Toruel copper-silver property, with more than two contiguous claims, and additional potash properties in Punta Colorada, Pedernal and El Carmen.

Marifil’s sizable portfolio of cobalt and lithium claims in what is recognized as the world’s most prolific mining jurisdiction for these resources strategically positions the company to benefit as global initiatives push demand for lithium-ion batteries toward a frenzy. Zion Market Research, a leading research and consulting firm, has forecast that the lithium-ion battery market could hit $67 billion by 2022, realizing a CAGR of more than 13.7% from 2017-2022. Both lithium and cobalt are major components of these energy storage solutions, with industry data indicating that the battery industry currently consumes roughly 42 percent of global cobalt production.

The company is reviving a lithium exploration program that was active in Argentina a decade ago, building on an unexplored mine it owns there. Marifil will utilize a large proprietary geologic and geochemical data base it developed during its 2009 lithium exploration program in the Salta and Catamarca province sites to resume lithium exploration in the region.

Applications for a second mine and negotiations to purchase a third property are underway, which would establish a significant property portfolio of ‘salar’ brine evaporation lakes. Hydrothermal solutions emanating from regional faults in area volcanoes often enrich the brine with lithium, boron, potassium and magnesium.

In addition to nearly 152,000 acres of lithium-staked properties, Marifil owns 887 acres of land for cobalt exploration and 91,565 acres of gold mining rights in an advanced exploration stage in San Roque that company engineers indicate has high gold discovery potential with “excellent infrastructure and mining friendly politics.”

To date, more than $7.5 million has been invested assessing Marifil’s flagship San Roque gold property, including nearly 16,000 meters of diamond core drilling. The property is jointly owned by Marifil and Novagold Resources, with Marifil holding a 51% stake and serving as the current project operator. The company recently commenced a drilling campaign to further evaluate several deposits of significant gold-silver-indium-lead-zinc mineralization on a 4-kilometer-long zone.

Marifil has closed a private placement funding for $2 million that will inject additional life into the company. Proceeds from the funding will benefit acquisition plans, the ongoing drilling program at Marifil’s gold claim and other output from its general working capital accounts.

Robert Abenante, a chartered professional account, serves as president and chief executive officer of the company. He has extensive experience in the public markets and has served as an officer and director of several public and private companies across various industries, with particular success in the mining sector.

Marifil Mines Ltd. (MFMLF), closed the day's trading session at $0.10412, up 16.47%, on 39,200 volume with 7 trades. The average volume for the last 3 months is 24,977 and the stock's 52-week low/high is $0.009/$0.165.

Recent News


Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today shares it has started formulating a full spectrum CBD beverage utilizing its University of Central Oklahoma Provisional Patent to improve immune system functions. Also today, the company was highlighted in a report on the overall cannabis sector has been on a tear for the past few days as yesterday marked the end of prohibition in Canada, the largest country to date to legalize recreational marijuana.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $1.552, up 7.03%, on 102,145 volume with 122 trades. The average volume for the last 3 months is 96,587 and the stock's 52-week low/high is $0.421/$2.45.

Recent News


Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Pure Applied Sciences, a wholly own subsidiary of Cannabis Strategic Ventures, Inc. (OTC: NUGS), has announced that “PureOrganix™,” their brand of high-quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP), is now available in dispensaries in California. Furthermore, PureOrganix™ plans to expand its national and international shelf-presence in states with legal markets and Canada in the next year. Also today, the company was highlighted in a report explaining that an increasing number of Major Corporations are revving up for what should be an inevitable and growing widespread legalization of Cannabis use across North America.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $3.95, up 7.05%, on 41,836 volume with 175 trades. The average volume for the last 3 months is 104,798 and the stock's 52-week low/high is $0.031/$7.13.

Recent News


Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces it has been granted two new US patents. Lexaria now has six granted patents in the US and four granted patents in Australia. All ten of these patents are within Lexaria's first patent family, "Food and Beverage Compositions Infused with Lipophilic Active Agents and Methods of Use Thereof". Also today, the company was highlighted in Venture Breakfast Bits, by 24/7 Market News Full press release.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.80, up 7.78%, on 557,450 volume with 580 trades. The average volume for the last 3 months is 220,043 and the stock's 52-week low/high is $0.33/$2.54.

Recent News


Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software, Inc. (OTC:PFSF) (“Pacific Software” or the “Company”), an emerging development technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms, today announces its role as a co-sponsor of “Latin America Night” at the 124th session of the Canton Fair PDC (Product Development Council) Design Show in Guangzhou (Canton) China.

Pacific Software, Inc. (PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $4.75, even for the day. The average volume for the last 3 months is 9 and the stock's 52-week low/high is $4.00/$5.25.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX)., Inc. (OTCQB: CIIX) ("CIIX" or "the Company"), the premier financial information website for Chinese-speaking investors, today announced its operational and financial summary for its First Quarter Fiscal Year 2019. Also today, the company was highlighted in an article from CannabisNewsWire, examining the cloud of uncertainty in the minds of Canadians working in the legal marijuana industry may have lifted a little after the U.S. Customs and Border Protection Administration (CBP) put up an update on its website stating that cannabis industry workers may be “generally” admissible into the U.S. in case their travel isn’t connected to their work.

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.89, off by 1.11%, on 495,489 volume with 305 trades. The average volume for the last 3 months is 610,593 and the stock's 52-week low/high is $0.365/$1.58.

Recent News


First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF), a client of NNW and a vertically integrated North American pure-play cobalt company. To view the full publication, titled “Cobalt’s Importance Underscored by Critical Minerals Listing, Rising EV Sales,” visit: Also today, NetworkNewsWire released a report on the company detailing how FTSSF is beginning to play its cards as it contemplates the possibilities of initiating North American production of the in-demand metal from facilities in eastern Canada.

First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.2167, off by 1.50%, on 125,386 volume with 40 trades. The average volume for the last 3 months is 219,673 and the stock's 52-week low/high is $0.1983/$1.3041.

Recent News


DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

DPW Holdings Inc. (NYSE:DPW) was highlighted today in an article explaining how cryptomining remains a lucrative arm of the overall cryptocurrency marketplace as leaders in the industry aim to capture value through advanced mining techniques and state of the art facilities.

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.3115, off by 2.04%, on 837,183 volume with 1,088 trades. The average volume for the last 3 months is 1,552,679 and the stock's 52-week low/high is $0.306/$5.95.

Recent News


Sunniva, Inc. (CSE: SNN) (OTC: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF), which has a cannabis concentrate extraction services agreement Cannabis Strategic Ventures, Inc. (OTC: NUGS), was highlighted today in coverage of the news that NUGS has announced that “PureOrganix™,” their brand of high-quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP), is now available in dispensaries in California. Furthermore, PureOrganix™ plans to expand its national and international shelf-presence in states with legal markets and Canada in the next year.

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $3.93, off by 1.75%, on 60,192 volume with 186 trades. The average volume for the last 3 months is 83,750 and the stock's 52-week low/high is $3.61/$16.00.

Recent News


QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

NetworkNewsAudio announces the Audio Press Release (APR) titled “Changes in the Lithium Market Drive Growth in Canadian Mining,” featuring QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ). To hear the NetworkNewsAudio version, visit: To read the full editorial, visit:

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.2434, off by 5.19%, on 72,255 volume with 46 trades. The average volume for the last 3 months is 117,683 and the stock's 52-week low/high is $0.168/$1.46.

Recent News


Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

YGYI, Inc. (NASDAQ:YGYI), a leading omni-direct lifestyle company, announces that its hemp-derived cannabidiol (CBD) Hemp FX products are now available for purchase online at the fully transactional website Also today, NetworkNewsWire released a report on the company postulating that, if diversification is the road to portfolio efficiency, then the expansion of its HempFX product line should take Youngevity International, Inc. (NASDAQ: YGYI) closer to optimizing its risk-return position.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $11.52, off by 6.19%, on 681,766 volume with 3,563 trades. The average volume for the last 3 months is 428,612 and the stock's 52-week low/high is $3.167/$16.25.

Recent News


RYU Apparel, Inc. (TSX.V: RYU) (OTC: RYPPF) (FRA: RYA)

The QualityStocks Daily Newsletter would like to spotlight RYU Apparel, Inc. (RYPPF).

RYU Apparel Inc. (TSX VENTURE: RYU.V, OTCQB: RYPPF), creators of urban athletic apparel, is pleased to share hyperlocal media coverage of the brand's profile, in the printed edition of Los Angeles Confidential – The Men's Issue.

Engineered for the fitness, performance and lifestyle of the athletically-minded, RYU Apparel, Inc. (DBA RYU \ Respect Your Universe) (TSX-V: RYU) (OTC: RYPPF) (FRA: RYA) develops, markets and distributes apparel, bags and accessories for active people living their lives with integrity. Headquartered in Vancouver, Canada, with with four stores located in Greater Vancouver Area, British Columbia and one in Toronto, RYU opened its first U.S.-based store at the iconic Abbot Kinney Boulevard in Venice California, on August 2, 2018. Additional retail locations are slated to open soon in Etokicoke, Ontario, Canada; Brooklyn, New York; and Newport Beach, California, with plans to establish nearly two dozen more store locations by the end of 2022.

Respect Your Universe’s award-winning brand celebrates, encourages and respects an individual’s choices and journey in life, promoting a fitness lifestyle culture. Innovatively designed without compromise and tailored for fit, comfort and durability, RYU exists to facilitate human performance. RYU’s urban athletic apparel and accessories product line has been featured by some of the most influential fitness and outdoor lifestyle publications and social media connectors.

The company recently was honored in Madrid, Spain, as a 2018 Finalist in the World Retail Awards in the categories of “Retail Start Up of the Year” and “Social Media Campaign of the Year,” (#RYUOneMoreRep). RYU is one of only two Canadian companies that qualified as finalists among many global retailers across all categories of the World Retail Awards annual event. The World Retail Awards have been recognizing the very best retailers and retail initiatives across a range of categories since 2007.

Marcello Leone, CEO of RYU, said the company’s inclusion in the prestigious lineup of finalists was gratifying, stating, “Being chosen by the World Retail Awards is a fantastic accolade. We are proud to be among a group of global peers that are considered to become the next generation of iconic brands. #RYUOneMoreRep Media Campaign is also another confirmation of the social aspect that permeates our brand and the impact we are having in our community.”

In addition to its retail locations, RYU generates sales through its e-commerce platform and has developed strategic relationships with companies such as Global-E, Netamorphosis, Fancy and the NHL Vancouver Canucks to expand its reach. RYU is also building connections with influential leaders and social media influencers who represent the company’s values of aliveness, bold expression, curiosity, discipline and respect. Under RYU’s Connector Program, each leader actively engages in community charities, volunteer efforts and participates in charity programs. Among the famous personalities and community leaders connecting with the RYU brand are:

  • Alexandra Ianculescu, a Canadian National Team Olympic Speed Skater
  • Ben Carr, professional trainer
  • Tori Katongo, personal trainer, singer, actor, dancer
  • Simon “Thor” Damborg, head coach at Raincity Athletics
  • Cassie Hawrysh, a Canadian National Team Skeleton Racer
  • Dai Manuel, lifestyle mentor and author of “The WholeLife Manifesto”

Company CEO Leon is the founder of Naturo Group Investment Inc., a company that sells nutritional beverages, and also is the former VP of operations and president of LEONE, an independent high fashion specialty store in Vancouver, Canada. Chief Financial Officer Pedro Villa is a certified CPA who has held several senior positions in various North American companies. Brett Pawson, senior VP of retail and operations, has more than 15 years of experience in sales and operations in the wellness, consumer goods and retail sectors.

RYU’s strategic focus is on becoming a global leader as a fitness and training apparel and accessories brand for athletes in multiple disciplines. RYU’s goal is to facilitate human performance by honoring and celebrating the extraordinary oneness of humanity by respecting each other’s differences – Respect Your Universe.

RYU Apparel, Inc. (RYPPF), closed the day's trading session at $0.1466, off by 0.88%, on 445,118 volume with 94 trades. The average volume for the last 3 months is 92,774 and the stock's 52-week low/high is $0.0035/$0.132.

Recent News


Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Sugarmade, Inc. (OTC: SGMD), a client of CNW focused on investing in products and brands with disruptive potential. To view the full publication, titled “Hemp and CBD Set to Eclipse the THC Marijuana Market,” visit: Also today, the company was highlighted in an article examining how an increasing number of Major Corporations are revving up for what should be an inevitable and growing widespread legalization of Cannabis use across North America. Additionally, NetworkNewsWire released a report on the company detailing how SGMD is perfectly poised for success, amid spending on legal cannabis that is projected to quadruple to over $47 billion over the next decade, from its present level of about $11 billion (

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include:;; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.


CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.1328, off by 8.22%, on 4,011,952 volume with 532 trades. The average volume for the last 3 months is 2,173,550 and the stock's 52-week low/high is $0.023/$0.43.

Recent News


American Premium Water Corp. (HIPH)

The QualityStocks Daily Newsletter would like to spotlight American Premium Water Corp. (HIPH).

American Premium Water Corporation (OTC:HIPH), which manufactures CBD infused beverages for SinglePoint Inc. (OTC:SING), was highlighted today in an article covering SInglePoint’s announcement of the addition of three new products to

American Premium Water Corp. (HIPH), headquartered in Playa Vista, California, is a diversified holding company, manufacturer, distributor and marketer of branded consumer products. HIPH, the acronym for “Hi-Power of Hydro,” maintains a portfolio of subsidiaries catering to the health-conscious consumer and luxury fashion brand connoisseur. The company’s two main pillars focus on the development of health and beauty biotech, dedicated to unlocking the power of hydrogen and nanotechnologies. Paired with cannabidiol or “CBD” in a unique beverage, the technology is proving to be a significant health and wellness option for astute consumers.

Among the company’s holdings are:

  • LALPINA Hydro beverages mix hydrogen with nanotechnology into consumer beverages that combine the best of health, nutrition and fitness to deliver short and long-term therapeutic health benefits. LALPINA Hydro utilizes atomic molecular hydrogen, or diatomic hydrogen, which converts antioxidants in the body to H2O to further enhance hydration, which helps increase endurance, reduce lactic acid and melt away fatigue. Over 500 peer-reviewed articles demonstrate hydrogen to have therapeutic potential in essentially every organ of the human body and in 150 different human disease models.
  • LALPINA Hydro CBD is a technically superior CBD-infused beverage. Using hydro and nanotechnology, LALPINA Hydro CBD encapsulates water molecules with cannabidiol molecules, making them infinitely more bioavailable and accelerating delivery to the body’s cells and tissues. Each bottle of LALPINA Hydro CBD contains 3 million nanograms of CBD free from the psychoactive compound THC (tetrahydrocannabinol). HIPH is the first to introduce a hydro-nano CBD-infused beverage on the market, which is a more effective delivery mechanism for administering CBD into the blood stream than traditional beverages or oils, with up to a 90 percent higher absorption rates.

The company recently signed a distribution agreement for its subsidiary, LALPINA Hydro CBD, to sell its beverages to two SinglePoint, Inc. (OTCQB: SING) e-commerce channels: and SING is a technology and investment company with a portfolio that includes mobile payments, blockchain solutions and ancillary cannabis services. HIPH will drop ship its product to the customers.

HIPH CEO Ryan Fishoff said the e-commerce arrangements “could bring in excess of a million of revenue over the life of the agreement.” The agreement serves as a pillar of the company’s e-commerce distribution strategy, driving awareness and impressions for the LALPINA brand.

In addition, HIPH seeks to market emerging fashion brands and leverage its relationship with classic retail partners while incorporating disruptive blockchain technologies to expand its retail footprint with the following:

  • Gents, a producer of luxury hats and other fine accessories and apparel, was acquired in September 2017. Gents is distributed across many luxury retail outlets including Saks Fifth Avenue, Bloomingdales, Nordstrom, and other high-end channels. The company added the Worthy streetwear brand to its portfolio in June 2018.
  • HIPH also acquired the license to operate the FashionCoinX exchange, a blockchain exchange focused on creating utility tokens for the fashion industry, and created THRD Coin, a multi-branded utility rewards token that is also the first token to be traded on the exchange. The company is leveraging its retail footprint and expertise in the fashion and apparel space with the burgeoning blockchain sector.

American Premium Water Corp. (HIPH), closed the day's trading session at $0.0959, off by 18.73%, on 32,258,642 volume with 1,865 trades. The average volume for the last 3 months is 15,115,552 and the stock's 52-week low/high is $0.0035/$0.132.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.